Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
atlanto-axial subluxation
bone biopsy
cornea, opacity of
deafness
foam cells
genetic neurologic disorders
genu valgum
hearing loss
kyphoscoliosis, neurologic causes of
Morquio syndrome
mucopolysaccharidoses
myelopathy
osteoporosis
paraparesis, spastic
pectus carinatum
respiratory failure
review article
sensorineural hearing loss
short neck
short stature
spinal cord, compression of
Showing articles 700 to 750 of 1316 << Previous Next >>

A Controlled Study of Intravenous Immunoglobulin Combined with Prednisone in the Treatment of IBM
Neurol 56:323-327, Dalakas,M.C.,et al, 2001

A Case of Immunotherapy-Responsive Eastern Equine Encephalitis with Diffusion-Weighted Imaging
Neurol 56:420-421, Golomb,M.R.,et al, 2001

Deterioration Following Improvement with tPA Therapy: Carotid Thrombosis and Reocclusion
Neurol 56:568-570, Burgin,W.S. &Alexandrov,A.V., 2001

Randomized Controlled Trial of IVIg in Untreated Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Neurol 56:445-449, Mendell,J.R.,et al, 2001

Clinical Deterioration Following Improvement in the NINDS rt-PA Stroke Trial
Stroke 32:661-668, Grotta,J.C.,et al, 2001

Spontaneous Intracerebral Hemorrhage
NEJM 344:1450-1460, Qureshi,A.I.,et al, 2001

Most Commonly Asked Questions About Intra-arterial Thrombolysis
The Neurologist 7:127-131, Wechsler,L.R., 2001

Utilization of Intravenous Tissue-Type Plasminogen Activator for Ischemic Stroke at Academic Medical Centers
Stroke 32:1061-1068, Claiborne Johnston,S.,et al, 2001

Intravenous tPA for Ischemic Stroke Team Performance Over Time, Safety, and Efficacy in a Single-Center, 2-Year Experience
Stroke 32:1074-1078, Koennecke,H.,et al, 2001

Benefits of Perfusion MR Imaging Relative to Diffusion MR Imaging in the Diagnosis and Treatment of Hyperacute Stroke
AJNR 22:915-921,806, Sunshine,J.L.,et al, 2001

Community Use of Intravenous Tissue Plasminogen Activator for Acute Stroke
Stroke 32:861-865, Katzan,I.L.,et al, 2001

Cocaine-Induced Persistent Dyskinesias
Neurol 56:964-965, Weiner,W.J.,et al, 2001

Memory Impairment in Abstinent MDMA ("Ecstasy") Users: A Longitudinal Investigation
Neurol 56:966-969, Zakzanis,K.K. & Young,D.A., 2001

Why Are Stroke Patients Excluded from TPA Therapy?
Neurol 56:1015-1020, Barber,P.A.,et al, 2001

Safety of Intra-Arterial Thrombolysis in the Postoperative Period
Stroke 32:1365-1369, Chalela,J.A.,et al, 2001

Thrombolysis of Extracranial and Intracranial Arteries After IV Abciximab
Neurol 56:1582-1584, Houdart,E.,et al, 2001

Rescue Treatment with Abciximab in Acute Ischemic Stroke
Neurol 56:1585-1587, Lee,K.Y.,et al, 2001

CT Angiography in the Rapid Triage of Patients with Hyperacute Stroke to Intraarterial Thrombolysis: Accuracy in the Detection of Large Vessel Thrombus
J Comput Assist Tomogr 25:520-528, Lev,M.H.,et al, 2001

Brain Magnetic Resonance Imaging in 23 Patients with Mucopolysaccharidoses and the Effect of Bone Marrow Transplantation
Ann Neurol 50:79-92, Seto,T.,et al, 2001

Cooling for Acute Ischemic Brain Damage (COOL AID)
Stroke 32:1847-1854, Krieger,D.W.,et al, 2001

Treatment with Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients with Ischemic Stroke Treated in Community Hospitals
Stroke 32:1832-1839,1840, Reed,S.D.,et al, 2001

Randomized Controlled Trial of Intravenous Immunoglobulin Versus Oral Prednisolone in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Ann Neurol 50:195-201, Hughes,R.,et al, 2001

Toxic Leukoencephalopathy
NEJM 345:425-432, Filley,C.M. &Kleinschmidt-DeMasters,B.K., 2001

Effects of Ecstasy (MDMA) on the Brain in Abstinent Users:Initial Observations with Diffusion and Perfusion MR Imaging
Radiology 220:611-617, Reneman,L.,et al, 2001

New Imaging Strategies for Patient Selection for Thrombolytic and Neuroprotective Therapies
Neurol 57:S48-S52, Warach,S., 2001

Intra-Arterial Thrombolysis
Neurol 57:S58-S60, Saver,J.L., 2001

Parenchymal Hyperdensity on Computed tomography after Intra-Arterial Reperfusion Therapy for Acugte Middle Cerebral Artery Occlusion,Incidence and Clinical Significance
Stroke 32:2042-2048, Nakano,S.,et al, 2001

Early Carotid Endarterectomy for Critical Carotid Artery Stenosis After Thrombolysis Therapy in Acute Ischemic Stroke in the Middle Cerebral Artery
Stroke 32:2075-2080, McPherson,C.M.,et al, 2001

Utility of Perfusion-Weighted CT Imaging in Acute Middle Cerebral Artery Stroke Treated with Intra-Arterial thrombolysis,Prediction of Final Infarct Volume and Clinical Outcome
Stroke 32:2021-2028, Lev,M.H.,et al, 2001

Nonrandomized Comparison of Local Urokinase Thrombolysis Versus Systemic Heparin Anticoagulation for Superior Sagittal Sinus Thrombosis
Stroke 32:2310-2317, Wassay,M.,et al, 2001

Graduating Neurology Residents' Experience with IV tPA for Acute Stroke
Neurol 57:1729-1730,1532, Cucchiara,B.L. &Kasner,S.E., 2001

Cerebral Hemorrhage After Intra-arterial Thrombolysis for Ischemic Stroke
Neurol 57:1603-1610, Kase,C.S.,et al, 2001

CT-Based Assessment of Acute Stroke
Stroke 32:2543-2549, Kilpatrick,M.M.,et al, 2001

Time Course of Tissue Plasminogen Activator-Induced Recanalization in Acute Cardioembolic Stroke
Stroke 32:2821-2827, Molina,C.A.,et al, 2001

Lack of Clinical Significance of Early Ischemic Changes on Computed Tomography in Acute Stroke
JAMA 286:2830-2838, Patel,S.C.,et al, 2001

Intravenous Tissue-Type Plasminogen Activator Therapy for Ischemic Stroke
Arch Neurol 58:2009-2013, Grotta,J.C.,et al, 2001

Acute Stroke Care in Non-urban Emergency Departments
Neurol 57:2006-2012, Burgin,W.S.,et al, 2001

Diffusion-perfusion MRI Characterization of Post-recanalization Hyperperfusion in Humans
Neurol 57:2015-2021, Kidwell,C.S.,et al, 2001

Thrombolysis in Patients with Transient Neurologic Deficits
Neurol 57:2125-2128, Lyden,P.,et al, 2001

Thrombolytic Therapy in Acute Ischemic Stroke Patients With Cardiac Thrombus
Neurol 57:2122-2125, Derex,L.,et al, 2001

Treatment of Acute Basilar Artery Thrombosis With a Combination of Systemic Alteplase and Tirofiban, a Nonpeptide Platelet Glycoprotein IIb/IIIa Inhibitor: Report of Four Cases
Radiology 221:795-801, Junghans,U.,et al, 2001

High-dose Intravenous Immune Globulin for Stiff-person Syndrome
NEJM 345:1870-1876, Dalakas,M.B.,et al, 2001

Systematic Review of Immunomodulatory Drugs for the Treatment of People with Multiple Sclerosis: Is There Good Quality Evidence on Effectiveness and Cost?
JNNP 70:574-579, Bryan,J.,et al, 2001

Moyamoya-like Vasculopathy from Cocaine Dependency
AJNR 21:1008-1010, Storen,E.C.,et al, 2000

Selective Infusion of Urokinase and Thrombectomy in the Treatment of Acute Cerebral Sinus Thrombosis
AJNR 21:143-145, Novak,Z.,et al, 2000

Superior Sagittal Sinus Thrombosis Due to Lithium:Local Urokinase Thrombolysis Treatment
Neurol 54:532-533, Wasay,M.,et al, 2000

Identification of lacunar Infarcts Before Thrombolysis in the ECASS I Study
Neurol 54:684-688, Toni,D.,et al, 2000

rtPA Intravenous Thrombolysis in Anterior Choroidal Artery Territory Stroke
Neurol 54:666-673, Trouillas,P.,et al, 2000

Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000

Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000



Showing articles 700 to 750 of 1316 << Previous Next >>